AI For Pharma Growth
Today: #129 in Technology, Germany on our combined chart.
Chart positions today · South Africa
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like AI For Pharma Growth, try…
Ranking history · South Africa
Latest episodes
-
E239: How to Speed Up Drug Development Without Compromising Compliance
October 13, 2026 · 35 minIn this episode of AI For Pharma Growth, Dr Andree Bates speaks with Clara Bernardes, co-founder and CSO of Biorce, about how AI can accelerate clinical development without sacrificing compliance or scientific rigour. Biorce was born from…
-
E238: The diagnostic room: The Fifteen Failures Only Human Judgement Catches
October 6, 2026 · 39 minIn this solo episode of AI For Pharma Growth, Dr Andree Bates explores one of the biggest blind spots in pharma AI: the failures that can survive a normal review process even when the output sounds polished, plausible and well grounded. Dr…
-
E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss
September 29, 2026 · 30 minIn this episode of AI For Pharma Growth, Dr Andree Bates speaks with cancer biologist and health educator Rebecca Maff about how AI could help shift healthcare from treating disease to preventing it. Rebecca’s interest in prevention began…
-
E236: Why 90% of Trials Still Fail — and What AI Can (and Can't) Fix
September 22, 2026 · 34 minIn this episode of AI For Pharma Growth, Dr Andree Bates speaks with Raviv Pryluk, co-founder and CEO of PhaseV, about why so many clinical trials still fail and where AI can genuinely improve the odds. Raviv argues that failure is often…
-
E235: AI created a trust crisis and nobody is talking about it
September 15, 2026 · 31 minIn this episode of AI For Pharma Growth, Dr Andree Bates speaks with Dan Pratl, founder and CEO of Quadron Inc, about a trust problem emerging as AI moves deeper into pharma: how do organisations preserve confidence when more work is…
Show 7 more episodesShow fewer episodes
-
E234: The contrarian case for physics over data: can deterministic, training-free models beat ML in lead optimization?
September 8, 2026 · 44 minIn this episode of AI For Pharma Growth, Dr Andree Bates speaks with Dr. Jacek Marczyk, co-founder and CEO of BioDynLab, about a contrarian view of computational drug discovery: that the next leap may come not from more data and bigger…
-
E233: The Diagnostic Room: The AI Capability Problem Pharma Hasn't Named
September 1, 2026 · 43 minIn this solo episode of AI For Pharma Growth, Dr Andree Bates explores the AI capability problem pharma has not properly named: training that works in the room, but fails to hold inside the organisation. Dr Andree explains why one-off…
-
E232: The Early Readout: Upgrading the Interim Analysis to Catch Futility and Success Years Sooner
August 25, 2026 · 28 minIn this episode of AI For Pharma Growth, Dr Andree Bates speaks with Tom Coates, CEO of Presentient, about why interim analysis in clinical trials is ready for a major upgrade. Interim analyses allow sponsors to look at trial data…
-
E231: The Diagnostic Room: You didn't have an AI problem. You had a capability problem.
August 18, 2026 · 37 minIn this solo episode of AI For Pharma Growth, Dr Andree Bates explores why many pharma teams do not have an AI problem at all. They have a capability problem. Dr Andree starts with a simple question: when was your team last properly…
-
E230: The Last Untouched Dataset
August 11, 2026 · 24 minIn this episode of AI For Pharma Growth, Dr Andree Bates speaks with Nijat Ahmadov, CEO of Nucs AI, about molecular imaging as one of pharma’s most underused data assets. Nijat explains why PET, CT and other molecular imaging data remain…
-
E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026
August 4, 2026 · 33 minIn this episode of AI For Pharma Growth, Dr Andree Bates speaks with Jitesh Halai, founder and CEO of OneSC, about what the Qualified Person role should look like in a more proactive, digitally connected pharmaceutical supply chain. Jitesh…
-
E228: The Diagnostic Room: "We're Doing AI" Is Not a Board Answer
July 28, 2026 · 40 minIn this solo episode of AI For Pharma Growth, Dr Andree Bates explains why “we’re doing AI” is not a credible board answer, and why activity, pilots and steering committees are not the same as strategy. Dr Andree breaks down two common…

United States
Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
United Kingdom